Allerzone 0.1%: The Ultimate Guide to Mometasone Furoate by EGPI

Dermatology
✔️ Medically Reviewed by: Dr. Ahmad Baker, PharmD

Welcome to the comprehensive guide to Allerzone 0.1% Mometasone Furoate, brought to you by the Egyptian Group for Pharmaceutical Industries. In this article, we’ll delve into the intricacies of Allerzone, its formulations, pharmacological actions, indications, contraindications, and much more.

Overview of Allerzone

Allerzone is a pharmaceutical product manufactured by the Egyptian Group for Pharmaceutical Industries. It comes in three different formulations: ointment, lotion, and cream, each designed to cater to specific dermatological needs. Allerzone contains the active ingredient Mometasone Furoate, a synthetic corticosteroid known for its anti-inflammatory, antipruritic, and vasoconstrictive properties.

Company Background: Egyptian Group for Pharmaceutical Industries

The Egyptian Group for Pharmaceutical Industries (EGPI) is a renowned pharmaceutical company known for its commitment to quality and innovation. With a rich history spanning decades, EGPI has established itself as a leader in the pharmaceutical industry, consistently delivering high-quality products to meet the evolving needs of patients worldwide.

Understanding Mometasone Furoate

Mometasone Furoate is the generic name for the active ingredient found in Allerzone. It belongs to the class of corticosteroids and is widely used in the treatment of various inflammatory skin conditions. Mometasone Furoate works by inhibiting the production of inflammatory mediators, such as prostaglandins and leukotrienes, thereby reducing inflammation and relieving symptoms associated with dermatoses.

Exploring Allerzone Formulations

Let’s take a closer look at the different formulations of Allerzone and their unique characteristics.

Allerzone Ointment: Ingredients and Benefits

Allerzone ointment is formulated with a combination of active and inactive ingredients designed to provide targeted relief for inflammatory skin conditions. The ointment base helps to moisturize the skin while delivering the active ingredient, Mometasone Furoate, directly to the affected area. Common inactive ingredients in Allerzone ointment include Propylene Glycol Stearate, Hexylene Glycol, Phosphoric Acid, White Petrolatum, White Beeswax, and Purified Water.

Allerzone Lotion: Composition and Uses

Allerzone lotion is a lightweight formulation that is easily absorbed into the skin, making it ideal for treating larger areas of affected skin. The lotion contains a blend of active and inactive ingredients, including Isopropyl Alcohol, Hydroxypropyl Methylcellulose, Propylene Glycol, Monobasic Sodium Phosphate, Phosphoric Acid, and Purified Water. Allerzone lotion is commonly used to relieve symptoms associated with inflammatory skin conditions such as psoriasis and atopic dermatitis.

Allerzone Cream: Features and Applications

Allerzone cream is a rich, emollient formulation designed to provide intense hydration while delivering the active ingredient, Mometasone Furoate, to the skin. The cream base contains a variety of active and inactive ingredients, including Hexylene Glycol, Liquid Paraffin, Cremophor A25, Cetostearyl Alcohol, Vaseline, Glycerol, Cetyl Alcohol, Methyl Paraben, Propyl Paraben, Xanthan Gum, Citric Acid Anhydrous, Trisodium Citrate Anhydrous, and Purified Water. Allerzone cream is particularly effective for targeting dry, irritated skin and is commonly used in the management of inflammatory dermatoses.

Understanding Pharmacological Actions

Now, let’s explore how Allerzone exerts its therapeutic effects on the skin and why it’s considered an effective treatment for inflammatory dermatoses.

Mechanism of Action: How Allerzone Works

Allerzone contains Mometasone Furoate, a synthetic corticosteroid with potent anti-inflammatory properties. Corticosteroids like Mometasone Furoate are thought to act by inhibiting the production of inflammatory mediators in the body, thereby reducing inflammation and alleviating symptoms associated with various skin conditions.

Anti-inflammatory Properties of Mometasone Furoate

One of the primary mechanisms of action of Mometasone Furoate is its ability to suppress the inflammatory response in the skin. By inhibiting the production of inflammatory cytokines and chemokines, Mometasone Furoate helps to reduce redness, swelling, and itching associated with inflammatory skin conditions such as psoriasis and atopic dermatitis.

Antipruritic Effects: Soothing Itchy Skin

In addition to its anti-inflammatory properties, Mometasone Furoate also exhibits antipruritic effects, meaning it helps to relieve itching and discomfort associated with inflammatory skin conditions. By reducing inflammation and suppressing the release of itch-inducing substances in the skin, Mometasone Furoate provides much-needed relief for patients suffering from pruritic dermatoses.

Vasoconstrictive Properties: Managing Skin Conditions

Mometasone Furoate also has vasoconstrictive properties, meaning it can help to narrow blood vessels in the skin. This action helps to reduce redness and swelling associated with inflammatory skin conditions, providing patients with visible improvement in their symptoms. By targeting multiple aspects of the inflammatory response, Mometasone Furoate offers comprehensive relief for patients with corticosteroid-responsive dermatoses.

Pharmacokinetics of Allerzone

Understanding the pharmacokinetics of Allerzone is crucial for optimizing its therapeutic efficacy and ensuring patient safety. In this section, we’ll explore how Allerzone is absorbed, distributed, metabolized, and eliminated from the body.

Absorption Rates in Different Formulations

Studies have shown that the absorption of Allerzone varies depending on the formulation used. For example, approximately 0.4% of the cream 0.1%, 0.7% of the lotion 0.1%, and ointment 0.1% enter the circulation after 8 hours of contact on normal skin without occlusion. However, it’s important to note that inflammation or other disease processes in the skin may increase percutaneous absorption, leading to higher systemic exposure to Mometasone Furoate.

Factors Affecting Absorption

Several factors can influence the absorption of Allerzone, including the integrity of the skin barrier, the surface area of application, and the presence of occlusive dressings. In general, intact skin with minimal barrier dysfunction facilitates optimal absorption of Allerzone, while compromised skin barriers, such as those seen in patients with eczema or psoriasis, may lead to increased absorption and systemic exposure.

Distribution and Metabolism

After absorption, Mometasone Furoate is distributed throughout the body, where it undergoes hepatic metabolism primarily via cytochrome P450 enzymes. The metabolites are then excreted via the renal and biliary pathways. However, systemic exposure to Mometasone Furoate is generally low with topical administration, minimizing the risk of systemic adverse effects.

Elimination

The elimination half-life of Mometasone Furoate varies depending on individual factors such as age, hepatic function, and renal function. However, due to its low systemic absorption, Mometasone Furoate is rapidly eliminated from the body, with most of the drug being excreted within a few hours to days after application.

Indications for Allerzone Use

Allerzone is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses. Let’s explore the specific conditions for which Allerzone is prescribed and the guidelines for its use.

Approved Uses

Allerzone is primarily used to treat inflammatory skin conditions such as psoriasis and atopic dermatitis. These conditions are characterized by redness, swelling, itching, and scaling of the skin, all of which can significantly impact patients’ quality of life. By targeting the underlying inflammation, Allerzone helps to alleviate these symptoms and improve patients’ overall well-being.

Pediatric Use Guidelines and Safety Concerns

Allerzone (mometasone furoate) ointment 0.1% may be used in pediatric patients 2 years of age or older, although the safety and efficacy of prolonged use for longer than 3 weeks have not been established. It’s essential for healthcare providers to exercise caution when prescribing Allerzone to pediatric patients and to closely monitor for any adverse effects or signs of systemic absorption.

Safety Considerations in Pediatric Patients

Since the safety and efficacy of Allerzone ointment 0.1% have not been established in pediatric patients below 2 years of age, its use in this age group is not recommended. Children are more susceptible to the systemic effects of topical corticosteroids due to their higher ratio of skin surface area to body weight. Therefore, healthcare providers should weigh the potential benefits against the risks when prescribing Allerzone to pediatric patients.

Contraindications and Adverse Effects

Before prescribing Allerzone, it’s essential to be aware of any contraindications and potential adverse effects that may occur. Let’s explore these in detail to ensure safe and effective use of the medication.

Contraindications

Allerzone should not be used in patients with a known hypersensitivity to any of the components of the product. Individuals who have experienced allergic reactions or skin sensitivities to corticosteroids or any other ingredients in Allerzone should avoid using the medication to prevent further adverse reactions.

Potential Adverse Effects

While Allerzone is generally well-tolerated, some patients may experience local adverse reactions at the site of application. These reactions may include:

  • Paresthesia (tingling or prickling sensation)
  • Pruritis (itchiness)
  • Burning or stinging
  • Folliculitis (inflammation of hair follicles)
  • Signs of skin atrophy (thinning of the skin)
  • Furunculosis (boil-like lesions)

In addition, rare adverse effects such as shininess, telangiectasia (spider veins), loss of elasticity, and loss of normal skin markings may occur with the use of Allerzone lotion 0.1%. Patients should be advised to report any adverse reactions to their healthcare provider promptly.

Mitigating Risks

To minimize the risk of adverse effects, healthcare providers should:

  • Perform a thorough assessment of the patient’s medical history and allergies before prescribing Allerzone.
  • Educate patients on proper application techniques and potential side effects of the medication.
  • Monitor patients closely for any signs of adverse reactions, especially during the initial stages of treatment.
  • Consider alternative treatment options for patients who are at higher risk of adverse effects or who have a history of allergic reactions to corticosteroids.

Drug Interactions and Special Populations

Understanding potential drug interactions and safety considerations for special populations is essential when prescribing Allerzone. Let’s explore these aspects to ensure safe and effective use of the medication.

Drug Interactions

Currently, there is no data available on drug interactions with Allerzone. However, healthcare providers should remain vigilant and consider the potential for interactions when prescribing other medications concomitantly with Allerzone. Patients should be encouraged to inform their healthcare provider of all medications, including over-the-counter drugs and supplements, they are taking to prevent potential interactions.

Pregnancy and Lactation

Allerzone is not recommended during pregnancy due to potential risks to the fetus. While there are no adequate and well-controlled studies in pregnant women, animal studies have shown adverse effects on fetal development. Therefore, pregnant women should avoid using Allerzone unless the potential benefits outweigh the risks, and the medication is deemed necessary by a healthcare provider.

Similarly, caution should be exercised when Allerzone is administered to nursing women. While systemic absorption of topical corticosteroids is minimal, there is a risk of exposure to the infant through breast milk. Healthcare providers should weigh the potential benefits against the risks and consider alternative treatment options for lactating women.

Precautions for Special Populations

Special precautions should be taken when prescribing Allerzone to certain patient populations, including:

  • Pediatric Patients: Use caution when prescribing Allerzone to pediatric patients, especially those under 2 years of age. Monitor for signs of systemic absorption and adverse effects, and limit the duration of treatment as appropriate.
  • Geriatric Patients: Elderly patients may be more susceptible to the systemic effects of corticosteroids due to age-related changes in skin integrity and metabolism. Use caution and monitor closely for adverse effects in this population.
  • Patients with Skin Infections: Allerzone should be used with caution in patients with concomitant skin infections, as corticosteroids may exacerbate existing infections or delay wound healing. Consider appropriate antimicrobial therapy if necessary.

Packaging, Storage, and Patient Instructions

Proper packaging, storage, and patient instructions are crucial for ensuring the efficacy and safety of Allerzone. Let’s delve into these aspects to provide comprehensive guidance for healthcare providers and patients.

Packaging

Allerzone is available in three different formulations: ointment, lotion, and cream. Each formulation comes in specific packaging designed to ensure product stability and ease of use:

  • Allerzone Ointment 0.1%: Packaged in an aluminum tube of 25g.
  • Allerzone Cream 0.1%: Packaged in a carton box containing an aluminum tube of 25g cream covered with an HDPE cap and inner leaflet.
  • Allerzone Lotion 0.1%: Packaged in a plastic (polyethylene) bottle of 20ml.

Healthcare providers should ensure that the packaging is intact and undamaged before dispensing Allerzone to patients.

Storage Recommendations

To maintain the stability and efficacy of Allerzone, it should be stored under specific conditions:

  • Store Allerzone at a temperature not exceeding 30°C (86°F).
  • Keep the medication away from direct sunlight and moisture.
  • Ensure that the packaging is tightly closed when not in use to prevent contamination or evaporation of the product.

Patients should be advised to store Allerzone in a cool, dry place and to avoid exposing it to extreme temperatures or environmental factors that may compromise its stability.

Patient Instructions

Proper patient instruction is essential for the safe and effective use of Allerzone. Healthcare providers should provide detailed guidance on the following:

  • Usage Instructions: Instruct patients to apply a thin film of Allerzone ointment or cream to the affected skin areas once daily. For Allerzone lotion, advise patients to apply a few drops to the affected skin areas, including the scalp, once daily.
  • Application Technique: Demonstrate the proper application technique, including gentle massage until the medication disappears.
  • Avoidance of Occlusive Dressings: Advise patients not to cover or wrap the treated skin area with occlusive dressings unless directed by a physician, as this may increase systemic absorption.
  • Adherence to Treatment: Emphasize the importance of adhering to the prescribed treatment regimen and completing the full course of therapy, even if symptoms improve.


Frequently Asked Questions (FAQs)

Addressing common questions and concerns about Allerzone can help patients better understand the medication and its usage. Let’s explore some frequently asked questions and provide comprehensive answers to assist patients in their treatment journey.

Q1: What is Allerzone used for?

A: Allerzone is indicated for the relief of inflammatory and pruritic manifestations of corticosteroid-responsive dermatoses, such as psoriasis and atopic dermatitis. It helps alleviate symptoms such as redness, swelling, itching, and scaling of the skin.

Q2: How should I apply Allerzone?

A: Depending on the formulation prescribed (ointment, cream, or lotion), apply a thin film of Allerzone to the affected skin areas once daily. For lotion, apply a few drops to the affected areas, including the scalp, and massage gently until the medication disappears.

Q3: Can I cover the treated skin area with bandages?

A: It’s generally not recommended to bandage or wrap the treated skin area unless directed by a physician. Occlusive dressings may increase systemic absorption of Allerzone and should be used with caution under medical supervision.

Q4: What are the potential side effects of Allerzone?

A: Common side effects of Allerzone may include paresthesia (tingling), pruritis (itchiness), burning or stinging sensation, folliculitis, and signs of skin atrophy. These side effects are usually mild and transient. However, if you experience any severe or persistent reactions, consult your healthcare provider.

Q5: Is Allerzone safe for use during pregnancy and breastfeeding?

A: Allerzone is not recommended during pregnancy due to potential risks to the fetus. Pregnant women should consult their healthcare provider before using Allerzone. While there is limited data on the excretion of Mometasone Furoate in breast milk, caution should be exercised when using Allerzone while breastfeeding.

Q6: Can I use Allerzone on my face or other sensitive areas?

A: It’s important to follow your healthcare provider’s instructions regarding the application of Allerzone. Avoid using Allerzone on the face, underarms, or groin areas unless specifically directed by a physician, as these areas may be more sensitive to corticosteroids.

Q7: How long should I use Allerzone?

A: Use Allerzone for the duration prescribed by your healthcare provider. If no improvement is seen within 2 weeks, reassessment of the diagnosis may be necessary. Avoid prolonged use beyond the prescribed duration unless instructed by a physician.

Q8: Can I use other skincare products with Allerzone?

A: It’s best to consult your healthcare provider before using other skincare products concomitantly with Allerzone. While there are no known drug interactions, certain products may affect the absorption or efficacy of Allerzone.

Allerzone: Key Features

  • Forms: Available as ointment, lotion, and cream.
  • Active Ingredient: Mometasone furoate (1mg per gram).
  • Pharmacological Actions: Anti-inflammatory, antipruritic, vasoconstrictive.
  • Indications: Psoriasis, atopic dermatitis.
  • Contraindications: Hypersensitivity to components.
  • Adverse Effects: Paresthesia, pruritis, burning, folliculitis, skin atrophy.
  • Precautions: Avoid occlusive dressings, use cautiously in pediatrics.
  • Dosage & Administration: Apply thinly once daily, avoid occlusion.
  • Patient Instructions: External use only, avoid contact with eyes.
  • Storage: Store below 30°C, follow physician’s instructions.
  • Manufacturer: Egyptian Group for Pharmaceutical Industries Co. – Egypt

Note: Dietary supplements are not intended to diagnose, treat, cure, or prevent any diseases.

Allerzone: A Product of EGPI

EGPI, a leading pharmaceutical company founded in 2006, aims to expand its high-quality medicine production throughout the Middle East.

  • Founded in 2006
  • Sister company to Egyptian Group for Drug Trading (EGD), established in 1994
  • Focuses on the Egyptian market with plans to expand in the Middle East
  • Specializes in formulating, registering, and producing high-quality pharmaceutical products
  • Equipped with advanced technologies and extensive information resources
  • Staffed by experienced pharmacists and chemists
  • Maintains a portfolio of over 150 products across various therapeutic categories.
  • Employs more than 450 dedicated employees.
  • Operates 10 departments
Dr. Ahmad Baker

Dr. Ahmad Baker, PharmD

Senior Pharmacist & Health Educator

With over 23 years of clinical experience in hospital and community pharmacy across Egypt and Saudi Arabia, Dr. Ahmad specializes in reproductive health and pharmaceutical safety. He is dedicated to providing evidence-based guidance to empower patients in the MENA region.

Medical Disclaimer: This content is for educational purposes and reflects the latest pharmaceutical protocols. It is not a substitute for personal medical advice. Always consult Dr. Ahmad Baker or your healthcare provider before starting any treatment.